UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Efficacy and safety of galcanezumab for the prevention of episodic migraine: Results of the EVOLVE-2 Phase 3 randomized controlled clinical trial

Cephalalgia, 2018-07, Vol.38 (8), p.1442-1454

2018

Volltextzugriff (PDF)

Safety and efficacy of galcanezumab in patients for whom previous migraine preventive medication from two to four categories had failed (CONQUER): a multicentre, randomised, double-blind, placebo-controlled, phase 3b trial

Lancet neurology, 2020-10, Vol.19 (10), p.814-825

2020

Volltextzugriff (PDF)

Efficacy and safety of fremanezumab for chronic migraine prevention: Multicenter, randomized, double‐blind, placebo‐controlled, parallel‐group trial in Japanese and Korean patients

Headache, 2021-07, Vol.61 (7), p.1092-1101

2021

Volltextzugriff (PDF)

Improved quality of life with fremanezumab in Japanese and Korean patients with episodic and chronic migraine: Results of two multicenter, randomized, double‐blind, placebo‐controlled, parallel‐group clinical trials

Headache, 2023-10, Vol.63 (9), p.1304-1313

2023

Volltextzugriff (PDF)

Efficacy and safety of fremanezumab for episodic migraine prevention: Multicenter, randomized, double‐blind, placebo‐controlled, parallel‐group trial in Japanese and Korean patients

Headache, 2021-07, Vol.61 (7), p.1102-1111

2021

Volltextzugriff (PDF)

Validity and reliability of the self‐administered Visual Aura Rating Scale questionnaire for migraine with aura diagnosis: A prospective clinic‐based study

Headache, 2021-06, Vol.61 (6), p.863-871

2021

Volltextzugriff (PDF)

Prevalence and impact of visual aura in migraine and probable migraine: a population study

Scientific reports, 2022-01, Vol.12 (1), p.426-9, Article 426

2022

Volltextzugriff (PDF)

Safety and efficacy of rimegepant orally disintegrating tablet for the acute treatment of migraine in China and South Korea: a phase 3, double-blind, randomised, placebo-controlled trial

Lancet neurology, 2023-06, Vol.22 (6), p.476-484

2023

Volltextzugriff (PDF)

Burden of migraine and unmet needs from the patients’ perspective: a survey across 11 specialized headache clinics in Korea

Journal of headache and pain, 2021-05, Vol.22 (1), p.45-45, Article 45

2021

Volltextzugriff (PDF)

Early onset of efficacy with fremanezumab in patients with episodic and chronic migraine: subanalysis of two phase 2b/3 trials in Japanese and Korean patients

Journal of headache and pain, 2022-02, Vol.23 (1), p.24-24, Article 24

2022

Volltextzugriff (PDF)

Ventral Simultanagnosia as an Aura of Posterior Cortex Epilepsy

Journal of Clinical Neurology, 2024, 20(3), , pp.333-335

2024

Volltextzugriff (PDF)

Differences of Cluster Headache on the Basis of Sex in the Korean Cluster Headache Registry

Headache, 2019-11, Vol.59 (10), p.1722-1730

2019

Volltextzugriff (PDF)

Clinical features of chronic cluster headache based on the third edition of the International Classification of Headache Disorders: A prospective multicentre study

PloS one, 2019-08, Vol.14 (8), p.e0221155-e0221155

2019

Volltextzugriff (PDF)

Real-world experience with 240 mg of galcanezumab for the preventive treatment of cluster headache

Journal of headache and pain, 2022-12, Vol.23 (1), p.132-132, Article 132

2022

Volltextzugriff (PDF)

Preventive therapy with galcanezumab for two consecutive cluster bouts in patients with episodic cluster headache: an observational multicenter study

Journal of headache and pain, 2023-10, Vol.24 (1), p.136-136, Article 136

2023

Volltextzugriff (PDF)

Clinical features of cluster headache without cranial autonomic symptoms: results from a prospective multicentre study

Scientific reports, 2021-03, Vol.11 (1), p.6916-6916, Article 6916

2021

Volltextzugriff (PDF)

A phase 3, randomised, placebo-controlled study of erenumab for the prevention of chronic migraine in patients from Asia: the DRAGON study

Journal of headache and pain, 2022-11, Vol.23 (1), p.146-13, Article 146

2022

Volltextzugriff (PDF)

The impact of remission and coexisting migraine on anxiety and depression in cluster headache

Journal of headache and pain, 2020-05, Vol.21 (1), p.58-58, Article 58

2020

Volltextzugriff (PDF)

Temporal changes of circadian rhythmicity in cluster headache

Cephalalgia, 2020-03, Vol.40 (3), p.278-287

2020

Volltextzugriff (PDF)

Impact of cluster headache on employment status and job burden: a prospective cross-sectional multicenter study

Journal of headache and pain, 2018-09, Vol.19 (1), p.78-8, Article 78

2018

Volltextzugriff (PDF)

Clinical factors influencing the impact of cluster headache from a prospective multicenter study

Scientific reports, 2020-02, Vol.10 (1), p.2428-2428, Article 2428

2020

Volltextzugriff (PDF)

Long–Term Outcome After Discontinuation of CGRP-Targeting Therapy for Migraine

Current pain and headache reports, 2024-08, Vol.28 (8), p.743-751

2024

Volltextzugriff (PDF)

Field testing the diagnostic criteria of cluster headache in the third edition of the International Classification of Headache Disorders: A cross-sectional multicentre study

Cephalalgia, 2019-06, Vol.39 (7), p.900-907

2019

Volltextzugriff (PDF)

Update of Gepants in the Treatment of Chronic Migraine

Current pain and headache reports, 2023-10, Vol.27 (10), p.561-569

2023

Volltextzugriff (PDF)

Predictors of response to galcanezumab in patients with chronic migraine: a real-world prospective observational study

Neurological sciences, 2023-07, Vol.44 (7), p.2455-2463

2023

Volltextzugriff (PDF)

1 – 25 von 203

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(139)
Mit Volltextzugriff
(145)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Efficacy and safety of galcanezumab for the prevention of episodic migraine: Results of the EVOLVE-2 Phase 3 randomized controlled clinical trial

Safety and efficacy of galcanezumab in patients for whom previous migraine preventive medication from two to four categories had failed (CONQUER): a multicentre, randomised, double-blind, placebo-controlled, phase 3b trial

Efficacy and safety of fremanezumab for chronic migraine prevention: Multicenter, randomized, double‐blind, placebo‐controlled, parallel‐group trial in Japanese and Korean patients

Improved quality of life with fremanezumab in Japanese and Korean patients with episodic and chronic migraine: Results of two multicenter, randomized, double‐blind, placebo‐controlled, parallel‐group clinical trials

Efficacy and safety of fremanezumab for episodic migraine prevention: Multicenter, randomized, double‐blind, placebo‐controlled, parallel‐group trial in Japanese and Korean patients

Validity and reliability of the self‐administered Visual Aura Rating Scale questionnaire for migraine with aura diagnosis: A prospective clinic‐based study

Prevalence and impact of visual aura in migraine and probable migraine: a population study

Safety and efficacy of rimegepant orally disintegrating tablet for the acute treatment of migraine in China and South Korea: a phase 3, double-blind, randomised, placebo-controlled trial

Burden of migraine and unmet needs from the patients’ perspective: a survey across 11 specialized headache clinics in Korea

Early onset of efficacy with fremanezumab in patients with episodic and chronic migraine: subanalysis of two phase 2b/3 trials in Japanese and Korean patients

Ventral Simultanagnosia as an Aura of Posterior Cortex Epilepsy

Differences of Cluster Headache on the Basis of Sex in the Korean Cluster Headache Registry

Clinical features of chronic cluster headache based on the third edition of the International Classification of Headache Disorders: A prospective multicentre study

Real-world experience with 240 mg of galcanezumab for the preventive treatment of cluster headache

Preventive therapy with galcanezumab for two consecutive cluster bouts in patients with episodic cluster headache: an observational multicenter study

Clinical features of cluster headache without cranial autonomic symptoms: results from a prospective multicentre study

A phase 3, randomised, placebo-controlled study of erenumab for the prevention of chronic migraine in patients from Asia: the DRAGON study

The impact of remission and coexisting migraine on anxiety and depression in cluster headache

Temporal changes of circadian rhythmicity in cluster headache

Impact of cluster headache on employment status and job burden: a prospective cross-sectional multicenter study

Clinical factors influencing the impact of cluster headache from a prospective multicenter study

Long–Term Outcome After Discontinuation of CGRP-Targeting Therapy for Migraine

Field testing the diagnostic criteria of cluster headache in the third edition of the International Classification of Headache Disorders: A cross-sectional multicentre study

Update of Gepants in the Treatment of Chronic Migraine

Predictors of response to galcanezumab in patients with chronic migraine: a real-world prospective observational study

Suchergebnisse filtern